byiShook Opinion
Nov 12, 2024 - 11:15
Biotech stock Neurogene collapsed Tuesday after a patient experienced a serious side effect in the company's Rett syndrome study. The post Top 1% Biotech Neurogene Crashes, Wiping Out A Run, On A Serious Side Effect appeared first on Investor's Business Daily.
Biotech stock Neurogene collapsed Tuesday after a patient experienced a serious side effect in the company's Rett syndrome study.
The post Top 1% Biotech Neurogene Crashes, Wiping Out A Run, On A Serious Side Effect appeared first on Investor's Business Daily.